You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 879 Post-treatment neutrophil-to-lymphocyte ratio and gMDSCs as independent prognostic factors for treatment efficacy with monoclonal antibody NEO-201 and pembrolizumab

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
879 Post-treatment neutrophil-to-lymphocyte ratio and gMDSCs as independent prognostic factors for treatment efficacy with monoclonal antibody NEO-201 and pembrolizumab

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023396020
Dec 202374013
Jan 20246705
Feb 20245205
Mar 20245204
Apr 20246404
May 20243705
Jun 20243906
Jul 20242203
Aug 20243204
Sep 20245507
Oct 20243208
Nov 20242404
Dec 2024206
Jan 20252005
Feb 2025403
Mar 2025006
Apr 2025001
May 2025003
Jun 2025004
Total9720116